Genetic testing for high-risk individuals is already available for certain cancer-related genetic mutations. Carriers of genetic mutations that increase risk for cancer incidence can undergo enhanced surveillance, chemoprevention, or risk-reducing surgery. Early identification of inherited genetic risk for cancer, along with cancer-preventing interventions such as surgery or enhanced surveillance, can be lifesaving for high-risk individuals.
| Gene | Cancer types | Availability |
|---|
| BRCA1, BRCA2 | Breast, ovarian, pancreatic | Commercially available for clinical specimens |
| MLH1, MSH2, MSH6, PMS1, PMS2 | Colon, uterine, small bowel, stomach, urinary tract | Commercially available for clinical specimens |
1 komentarze:
test
Post a Comment